Unleashing the power of next generation cancer treatments
View Pipeline
Pipeline
AmMax has built a robust oncology pipeline by leveraging its translational expertise with its lead program, AMB-066, supported by compelling preclinical data and a well-established safety profile across 6 completed clinical trials.